Emirates Drug Establishment

Emirates Drug Establishment visits included facilities operated by Medisal Pharma and ADCAN Pharma, where production processes and quality assurance systems were reviewed

The mechanism seeks to address monopolistic dynamics that can limit market access, constrain pricing flexibility and increase vulnerability to supply interruptions

The Emirates Drug Establishment said the project forms part of a broader package of national initiatives aimed at bolstering pharmaceutical security

Consumers and distributors have been urged to verify batch numbers to ensure potentially impacted products are removed from circulation